Literature DB >> 2875319

Atherogenicity of blood serum from patients with coronary heart disease.

E I Chazov, V V Tertov, A N Orekhov, A A Lyakishev, N V Perova, K A Kurdanov, K A Khashimov, I D Novikov, V N Smirnov.   

Abstract

The sera from 62 of 68 patients with coronary heart disease (CHD) caused a two to five fold elevation in the intracellular cholesterol in primary cultures of subendothelial cells derived from grossly normal intima of human aorta. The sera from 33 of 42 healthy subjects did not show atherogenic properties in culture. Atherogenic potential correlated directly with the serum apolipoprotein-B-apolipoprotein A1 ratio, but not with the level of total cholesterol, high-density-lipoprotein cholesterol, apo-B, or apo-A1. The sera from patients with CHD also facilitated deposition of lipids in the medial smooth muscle cells of human aorta and mononuclear blood cells, though to a lesser degree. They had no such effect on endothelial cells of human aorta and umbilical vein, or human embryo fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875319     DOI: 10.1016/s0140-6736(86)92426-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  [Limited access to the international medical literature in Russia].

Authors:  Sergei V Jargin
Journal:  Wien Med Wochenschr       Date:  2012-06-12

Review 2.  Interrelationship of hypertension, plasma lipids and atherosclerosis.

Authors:  J M Krzesinski; P G Carlier; G L Rorive
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.

Authors:  A N Orekhov; E M Pivovarova; I A Sobenin; V V Yakushkin; V V Tertov
Journal:  Drugs       Date:  1992       Impact factor: 9.546

4.  Anti-atherosclerotic therapy based on botanicals.

Authors:  Alexander N Orekhov; Igor A Sobenin; Nikolay V Korneev; Tatyana V Kirichenko; Veronika A Myasoedova; Alexandra A Melnichenko; Mercedes Balcells; Elazer R Edelman; Yuri V Bobryshev
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2013-04

5.  Testing of serum atherogenicity in cell cultures: questionable data published.

Authors:  Sergei V Jargin
Journal:  Ger Med Sci       Date:  2012-01-31

6.  Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy.

Authors:  Alexander N Orekhov; Igor A Sobenin; Mikhail A Gavrilin; Alexei Gratchev; Svetlana Y Kotyashova; Nikita G Nikiforov; Julia Kzhyshkowska
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 7.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25

Review 8.  Hormesis and homeopathy: The artificial twins.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2014-11-28

9.  Approach to reduction of blood atherogenicity.

Authors:  Alexander N Orekhov; Alexandra A Melnichenko; Igor A Sobenin
Journal:  Oxid Med Cell Longev       Date:  2014-06-29       Impact factor: 6.543

Review 10.  Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy.

Authors:  Ekaterina A Ivanova; Alexander N Orekhov
Journal:  J Immunol Res       Date:  2016-01-18       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.